Sample size and statistical analysis
As per our institutional pilot study during the first wave of the COVID-19, the incidence of COVID-19 was considerably (P = 0.033) lower in the PEP group (10.6%) that received HCQ prophylaxis compared to the control group (19.5%) with absolute risk reduction of –8.9% pointsStudy design, screening and enrollment.